Our findings suggest that post-transcriptional regulation of FLOT1 by miRNA is a vital mechanism underlying cancer growth and metastasis, and miR-506 may serve as potential treatment target for regulating FLOT1 to inhibit the growth and metastasis of renal cancer. Here, FLOT1 is linked to renal carcinoma.